Novartis CEO Vas Narasimhan Announces Impressive Q2 2024 Results: 11% Net Sales Surge and Upgraded FY2024 Guidance

net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entr...

July 18, 2024 | Thursday | Company results
Mika Health, AstraZeneca, and Daiichi Sankyo Launch "UNITE" Initiative to Enhance Breast Cancer Treatment Experience

Mika Health, a global digital therapeutics developer specializing in meeting the needs of cancer patients, in collaboration with AstraZenecaand Daiichi S...

June 19, 2024 | Wednesday | News
UCB Presents Promising Data on Certolizumab Pegol for Pregnant Women and High RF RA Patients at EULAR 2024

  Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their do...

June 17, 2024 | Monday | News
Wyss Center and Dandelion Science Announce Pioneering AI Neuromodulation Partnership

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generat...

June 12, 2024 | Wednesday | News
Pfizer Celebrates 175 Years of Innovation and Global Healthcare Leadership

Landmark event marks Pfizer's enduring legacy, innovative achievements and commitment to help shaping the future of global healthcare By leveraging AI...

June 12, 2024 | Wednesday | News
Abu Dhabi Signs Landmark MoU with ADIO, Etihad Airways, and AD Ports Group to Become Global Pharma and Life Sciences Hub

BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...

June 10, 2024 | Monday | News
FDA Accepts Eisai and Biogen’s Application for Monthly Maintenance Dosing of Alzheimer's Drug LEQEMBI

Eisai Co.,  and Biogen announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Supplemental Biologics License Applicat...

June 10, 2024 | Monday | News
A Strategic Vision for Global Health: Investing in a Safer Future

Investing in Global Health for a Safer Future World Health Organization's (WHO) "All for Health, Health for All: Investment Case 2025–2028...

June 10, 2024 | Monday | News
lifespin GmbH and Acıbadem University Forge Global Alliance to Spearhead Precision Medicine Revolution

lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launc...

May 28, 2024 | Tuesday | News
Nxera Pharma's Partner, Neurocrine Biosciences, Initiates Phase 1 Study for Promising Investigational Compound, NBI-1117567

Nxera Pharma  notes that its partner Neurocrine Biosciences  a leading neuroscience-focused biopharmaceutical company, announced that it has init...

May 09, 2024 | Thursday | News
BrightInsight Teams Up with Google Cloud to Transform Patient Care with Advanced AI Solutions

BrightInsight, Inc, the trusted partner and platform driving value for top biopharma compliant digital health solutions, announced today that it will deplo...

May 07, 2024 | Tuesday | News
Driving Global Access to Medicines: A Conversation with Cem Zorlular, CEO of Er-Kim

  In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...

May 06, 2024 | Monday | Interview
Walgreens and Boehringer Ingelheim Forge Strategic Partnership to Democratize Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusiv...

May 03, 2024 | Friday | News
Beyfortus (nirsevimab) Proves Potent Against RSV Hospitalizations in Infants

New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the...

May 03, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close